These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 22777357)
1. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Zhang X; Cruz FD; Terry M; Remotti F; Matushansky I Oncogene; 2013 May; 32(18):2249-60, 2260.e1-21. PubMed ID: 22777357 [TBL] [Abstract][Full Text] [Related]
2. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG. Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming. Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876 [TBL] [Abstract][Full Text] [Related]
4. Efficient induction of pluripotent stem cells from granulosa cells by Oct4 and Sox2. Mao J; Zhang Q; Ye X; Liu K; Liu L Stem Cells Dev; 2014 Apr; 23(7):779-89. PubMed ID: 24083387 [TBL] [Abstract][Full Text] [Related]
5. Nuclear reprogramming with a non-integrating human RNA virus. Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591 [TBL] [Abstract][Full Text] [Related]
6. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261 [TBL] [Abstract][Full Text] [Related]
7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins. Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118 [TBL] [Abstract][Full Text] [Related]
8. Gata4 blocks somatic cell reprogramming by directly repressing Nanog. Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827 [TBL] [Abstract][Full Text] [Related]
9. A combined epigenetic and non-genetic approach for reprogramming human somatic cells. Han J; Sachdev PS; Sidhu KS PLoS One; 2010 Aug; 5(8):e12297. PubMed ID: 20808872 [TBL] [Abstract][Full Text] [Related]
10. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions. Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216 [TBL] [Abstract][Full Text] [Related]
11. Reprogramming cancer cells: back to the future. Lang JY; Shi Y; Chin YE Oncogene; 2013 May; 32(18):2247-8. PubMed ID: 22869153 [TBL] [Abstract][Full Text] [Related]
13. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. Farthing CR; Ficz G; Ng RK; Chan CF; Andrews S; Dean W; Hemberger M; Reik W PLoS Genet; 2008 Jun; 4(6):e1000116. PubMed ID: 18584034 [TBL] [Abstract][Full Text] [Related]
14. Defined factors induce reprogramming of gastrointestinal cancer cells. Miyoshi N; Ishii H; Nagai K; Hoshino H; Mimori K; Tanaka F; Nagano H; Sekimoto M; Doki Y; Mori M Proc Natl Acad Sci U S A; 2010 Jan; 107(1):40-5. PubMed ID: 20018687 [TBL] [Abstract][Full Text] [Related]
15. NANOG priming before full reprogramming may generate germ cell tumours. Grad I; Hibaoui Y; Jaconi M; Chicha L; Bergström-Tengzelius R; Sailani MR; Pelte MF; Dahoun S; Mitsiadis TA; Töhönen V; Bouillaguet S; Antonarakis SE; Kere J; Zucchelli M; Hovatta O; Feki A Eur Cell Mater; 2011 Nov; 22():258-74; discussio 274. PubMed ID: 22071697 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560 [TBL] [Abstract][Full Text] [Related]
17. Generation of Partially Reprogrammed Cells and Fully Reprogrammed iPS Cells by Plasmid Transfection. Kim JS; Choi HW; Hong YJ; Do JT Methods Mol Biol; 2016; 1357():85-95. PubMed ID: 25476445 [TBL] [Abstract][Full Text] [Related]
18. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. Zhao HX; Li Y; Jin HF; Xie L; Liu C; Jiang F; Luo YN; Yin GW; Li Y; Wang J; Li LS; Yao YQ; Wang XH Differentiation; 2010; 80(2-3):123-9. PubMed ID: 20510497 [TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell lines derived from human somatic cells. Yu J; Vodyanik MA; Smuga-Otto K; Antosiewicz-Bourget J; Frane JL; Tian S; Nie J; Jonsdottir GA; Ruotti V; Stewart R; Slukvin II; Thomson JA Science; 2007 Dec; 318(5858):1917-20. PubMed ID: 18029452 [TBL] [Abstract][Full Text] [Related]
20. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells. Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]